Rosanna Marsella,
Professor
Department:
Small Animal Clinical Sciences
Business Phone:
(352) 392-2235
Business Email:
marsella@ufl.edu
Accomplishments
Superior Accomplishment Award
2006
·
University of Florida
Clinical Investigator Award
2002
·
Florida Association of Kennel Clubs
Best Resident Presentation
1996
·
American Academy of Veterinary Dermatology
Best Resident Presentation
1996
·
American College of Veterinary Dermatology
Best Resident Presentation, Phi Zeta Research Day
1996
·
University of Florida
Best Resident Seminar
1994-1995
·
University of Florida
Teaching Profile
Courses Taught
2010-2011,2017-2024
VEM5335 Equine Medicine
2017-2024
VEM5388 Sa Dermatology
2008-2025
VEM5869 Vet. Dermatology Clerkship
2009-2025
VEM5387 Vet Dermatology
2018
GMS7980 Research for Doctoral Dissertation
2015-2016
VEM5171 Vet Pharmacology
2016
VEM5902 Supervised Teach Dev
2015
VME6934 Topics in Veterinary Medical Sciences
2010-2011,2013
VEM5115 Veterinary Histology
2006-2010
VEM5769 Core Clk Dermatology
2021
VME6905 Problems in Veterinary Medical Sciences
Board Certifications
-
DiplomateAmerican College of Veterinary Dermatology
Research Profile
Research Interests
– Immunology of allergic skin diseases
– Canine atopic dermatitis
– Pathogenesis and novel treatments
Publications
Academic Articles
2025
Antibiotic resistance in equine dermatology: what should we do?
Journal of the American Veterinary Medical Association.
263(7):927-931
[DOI] 10.2460/javma.24.11.0732.
[PMID] 40154276.
2025
In vitro use of a low-level laser therapy device inhibits growth of Malassezia pachydermatis.
American journal of veterinary research.
86(5)
[DOI] 10.2460/ajvr.24.11.0355.
[PMID] 40014931.
2025
Skin Barrier in Normal and Allergic Horses: What Do We Know?
Veterinary sciences.
12(2)
[DOI] 10.3390/vetsci12020091.
[PMID] 40005851.
2024
Autoimmune Dermatopathies of Horses.
The Veterinary clinics of North America. Equine practice.
40(2):237-251
[DOI] 10.1016/j.cveq.2024.04.001.
[PMID] 38821844.
2024
Interleukin 31 transcription in a canine model of acute atopic dermatitis does not correlate with T-cell infiltration.
Allergy.
79(6):1622-1625
[DOI] 10.1111/all.16105.
[PMID] 38532561.
2024
Investigation into the Effects of Allergen Exposure and Topical Vinegar and Water Spray on Skin Barrier Parameters in Atopic Dogs.
Veterinary sciences.
11(10)
[DOI] 10.3390/vetsci11100459.
[PMID] 39453051.
2024
Pruritic Horse: Approach to Allergic Skin Diseases in Horses.
The Veterinary clinics of North America. Equine practice.
40(2):219-235
[DOI] 10.1016/j.cveq.2024.05.002.
[PMID] 38852012.
2024
Studies Using Antibodies against Filaggrin and Filaggrin 2 in Canine Normal and Atopic Skin Biopsies.
Animals : an open access journal from MDPI.
14(3)
[DOI] 10.3390/ani14030478.
[PMID] 38338121.
2024
Trichohyalin gene expression is negatively correlated with the severity of dermatitis in a canine atopic dermatitis model.
Frontiers in veterinary science.
11
[DOI] 10.3389/fvets.2024.1396557.
[PMID] 39234173.
2023
Diving into dermatology.
Journal of the American Veterinary Medical Association.
261(S1):S4-S6
[DOI] 10.2460/javma.261.s1.s4.
[PMID] 37225152.
2023
Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology.
Veterinary dermatology.
34(3):175-208
[DOI] 10.1111/vde.13168.
[PMID] 37154488.
2023
Evolution of the Prevalence of Antibiotic Resistance to Staphylococcus spp. Isolated from Horses in Florida over a 10-Year Period.
Veterinary sciences.
10(2)
[DOI] 10.3390/vetsci10020071.
[PMID] 36851375.
2023
Immunolocalization and Expression of JAK1 and JAK3 in the Skin of Dust Mite-Sensitive Beagle Dogs before and after Allergen Exposure.
Veterinary sciences.
10(8)
[DOI] 10.3390/vetsci10080512.
[PMID] 37624299.
2023
Oclacitinib 10 years later: lessons learned and directions for the future.
Journal of the American Veterinary Medical Association.
261(S1):S36-S47
[DOI] 10.2460/javma.22.12.0570.
[PMID] 36944222.
2023
Skin biopsy guidelines: tips and advice from veterinary pathologists to practitioners.
Journal of the American Veterinary Medical Association.
261(S1):S114-S121
[DOI] 10.2460/javma.22.12.0586.
[PMID] 37037420.
2023
Topical Bacteriophage Therapy for Staphylococcal Superficial Pyoderma in Horses: A Double-Blind, Placebo-Controlled Pilot Study.
Pathogens (Basel, Switzerland).
12(6)
[DOI] 10.3390/pathogens12060828.
[PMID] 37375518.
2023
Transcription of interleukin 31 and its receptor by leukocytes after Culicoides sp stimulation is dose dependent but is not exaggerated in allergic horses or correlated with pruritus.
Journal of the American Veterinary Medical Association.
261(S1):S75-S85
[DOI] 10.2460/javma.22.12.0588.
[PMID] 37116871.
2022
Canine Epidermal Keratinocytes (CPEK) Grown in Monolayer Are Not Representative of Normal Canine Keratinocytes for Permeability Studies: Pilot Studies.
Veterinary sciences.
9(1)
[DOI] 10.3390/vetsci9010025.
[PMID] 35051109.
2022
Differences in Behavior between Normal and Atopic Keratinocytes in Culture: Pilot Studies.
Veterinary sciences.
9(7)
[DOI] 10.3390/vetsci9070329.
[PMID] 35878346.
2022
Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis.
Experimental dermatology.
31(4):628-632
[DOI] 10.1111/exd.14507.
[PMID] 34839557.
2021
Advances in our understanding of canine atopic dermatitis.
Veterinary dermatology.
32(6):547-e151
[DOI] 10.1111/vde.12965.
[PMID] 33891338.
2021
Atopic Dermatitis in Domestic Animals: What Our Current Understanding Is and How This Applies to Clinical Practice.
Veterinary sciences.
8(7)
[DOI] 10.3390/vetsci8070124.
[PMID] 34357916.
2021
Investigation on the Effect of Dose, Frequency and Duration of Allergen Exposure on Development of Staphylococcal Infections in a Chronic Model of Canine Atopic Dermatitis.
Veterinary sciences.
9(1)
[DOI] 10.3390/vetsci9010008.
[PMID] 35051092.
2021
Reduced IL-31 receptor alpha splice variant mRNA following allergen challenge in a canine model of atopic dermatitis.
Allergy.
76(10):3206-3209
[DOI] 10.1111/all.15005.
[PMID] 34255350.
2020
Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs.
Veterinary dermatology.
31(4):284-e69
[DOI] 10.1111/vde.12849.
[PMID] 32301565.
2020
Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing.
Immunogenetics.
72(4):241-250
[DOI] 10.1007/s00251-020-01162-w.
[PMID] 32219493.
2020
Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis.
BMC veterinary research.
16(1)
[DOI] 10.1186/s12917-020-02306-6.
[PMID] 32197613.
2019
Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
Archives of dermatological research…
311(10):795-800
[DOI] 10.1007/s00403-019-01963-4.
[PMID] 31446453.
2019
Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs.
Journal of the American Veterinary Medical Association.
254(11):1291-1300
[DOI] 10.2460/javma.254.11.1291.
[PMID] 31067173.
2018
A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
Veterinary dermatology.
29(5):439-e146
[DOI] 10.1111/vde.12660.
[PMID] 29926994.
2018
Evaluation on the effects of 0.1% Peumus boldus leaf and Spiraea ulmaria plant extract combination on bacterial colonization in canine atopic dermatitis: A preliminary randomized, placebo controlled, double-blinded study.
Research in veterinary science.
118:164-170
[DOI] 10.1016/j.rvsc.2018.02.006.
[PMID] 29482177.
2018
Investigation of the correlation of serum IL-31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs.
Veterinary dermatology.
29(1):69-e28
[DOI] 10.1111/vde.12500.
[PMID] 28983982.
2018
Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
Veterinary immunology and immunopathology.
197:93-101
[DOI] 10.1016/j.vetimm.2018.02.001.
[PMID] 29475513.
2017
Atopic Dermatitis in Animals and People: An Update and Comparative Review.
Veterinary sciences.
4(3)
[DOI] 10.3390/vetsci4030037.
[PMID] 29056696.
2017
Effects of PAR2 antagonist on inflammatory signals and tight junction expression in protease-activated canine primary epithelial keratinocytes.
Experimental dermatology.
26(1):86-88
[DOI] 10.1111/exd.13121.
[PMID] 27306682.
2017
Evaluation of the in vitro effect of Boldo and Meadowsweet plant extracts on the expression of antimicrobial peptides and inflammatory markers in canine keratinocytes.
Research in veterinary science.
115:255-262
[DOI] 10.1016/j.rvsc.2017.05.021.
[PMID] 28549300.
2017
Increased filaggrin-metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis.
Veterinary dermatology.
28(5):479-e111
[DOI] 10.1111/vde.12443.
[PMID] 28393458.
2017
Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis.
Veterinary dermatology.
28(6):577-e140
[DOI] 10.1111/vde.12467.
[PMID] 28736984.
2016
A comparative study of epidermal tight junction proteins in a dog model of atopic dermatitis.
Veterinary dermatology.
27(1):40-e11
[DOI] 10.1111/vde.12276.
[PMID] 26663564.
2016
Can ultraviolet light C decrease the environmental burden of antimicrobial-resistant and -sensitive bacteria on textiles?
Veterinary dermatology.
27(6):457-e121
[DOI] 10.1111/vde.12377.
[PMID] 27620856.
2016
Canine models of allergic skin disease.
Veterinary dermatology.
27(4):326-7
[DOI] 10.1111/vde.12311.
[PMID] 27273262.
2016
Decreased expression of caspase-14 in an experimental model of canine atopic dermatitis.
Veterinary journal (London, England : 1997).
209:201-3
[DOI] 10.1016/j.tvjl.2015.11.020.
[PMID] 26831171.
2016
Ticks associated with domestic dogs and cats in Florida, USA.
Experimental & applied acarology.
69(1):87-95
[DOI] 10.1007/s10493-016-0019-4.
[PMID] 26888081.
2016
Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study.
The Journal of investigative dermatology.
136(3):665-671
[DOI] 10.1016/j.jid.2015.11.001.
[PMID] 26876716.
2015
Evaluation of antimicrobial peptides and cytokine production in primary keratinocyte cell culture from healthy and atopic beagles.
Experimental dermatology.
24(4):317-9
[DOI] 10.1111/exd.12660.
[PMID] 25660992.
2015
Experimental model for peanut allergy by epicutaneous sensitization in atopic beagle dogs.
Experimental dermatology.
24(9):711-2
[DOI] 10.1111/exd.12776.
[PMID] 26014917.
2015
First report in a dog model of atopic dermatitis: expression patterns of protease-activated receptor-2 and thymic stromal lymphopoietin.
Veterinary dermatology.
26(3):180-5, e36
[DOI] 10.1111/vde.12203.
[PMID] 25940870.
2015
Introduction to the review articles by ICADA on the pathogenesis of atopic dermatitis in dogs.
Veterinary dermatology.
26(2):77-8
[DOI] 10.1111/vde.12207.
[PMID] 25808534.
2015
Review: Clinical and histological manifestations of canine atopic dermatitis.
Veterinary dermatology.
26(2):79-e24
[DOI] 10.1111/vde.12196.
[PMID] 25676252.
2015
Review: Innate immunity, lipid metabolism and nutrition in canine atopic dermatitis.
Veterinary dermatology.
26(2):104-e28
[DOI] 10.1111/vde.12199.
[PMID] 25728538.
2015
Review: Lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis.
Veterinary dermatology.
26(2):124-e32
[DOI] 10.1111/vde.12205.
[PMID] 25808535.
2015
Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.
Veterinary dermatology.
26(2):84-e25
[DOI] 10.1111/vde.12197.
[PMID] 25683702.
2015
Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis.
Veterinary dermatology.
26(2):95-e26
[DOI] 10.1111/vde.12198.
[PMID] 25703290.
2015
Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis.
Veterinary dermatology.
26(2):115-e30
[DOI] 10.1111/vde.12201.
[PMID] 25728611.
2015
Tight junction proteins in the canine epidermis: a pilot study on their distribution in normal and in high IgE-producing canines.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
79(1):46-51
[PMID] 25673908.
2014
A Prospective, Double-Lbinded, Controlled Pilot Study To Evaluate the Effects of Cyclosporine (Atopica) On Skin Barrier Function in Canine Atopic Dermatitis By Measurement of Trans-Epidermal Water Loss
International Journal of Applied Research in Veterinary Medicine.
12(1):18-23
2014
First case report of ultrastructural cutaneous abnormalities in equine atopic dermatitis.
Research in veterinary science.
97(2):382-5
[DOI] 10.1016/j.rvsc.2014.06.012.
[PMID] 25048836.
2013
Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.
Veterinary dermatology.
24(3):329-36, e73
[DOI] 10.1111/vde.12031.
[PMID] 23668858.
2013
Does filaggrin expression correlate with severity of clinical signs in dogs with atopic dermatitis?
Veterinary dermatology.
24(2):266-e59
[DOI] 10.1111/vde.12007.
[PMID] 23398596.
2013
Equine allergy therapy: update on the treatment of environmental, insect bite hypersensitivity, and food allergies.
The Veterinary clinics of North America. Equine practice.
29(3):551-7
[DOI] 10.1016/j.cveq.2013.08.006.
[PMID] 24267674.
2013
Fixing the skin barrier: past, present and future–man and dog compared.
Veterinary dermatology.
24(1):73-6.e17
[DOI] 10.1111/j.1365-3164.2012.01073.x.
[PMID] 23331682.
2013
Investigation of the effect of probiotic exposure on filaggrin expression in an experimental model of canine atopic dermatitis.
Veterinary dermatology.
24(2):260-e57
[DOI] 10.1111/vde.12006.
[PMID] 23432387.
2012
An update on the treatment of canine atopic dermatitis.
Veterinary medicine (Auckland, N.Z.).
3:85-91
[DOI] 10.2147/VMRR.S28488.
[PMID] 30101088.
2012
Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis? A compilation of studies.
Veterinary dermatology.
23(3):238-e49
[DOI] 10.1111/j.1365-3164.2012.01055.x.
[PMID] 22575022.
2012
Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis.
Journal of the American Veterinary Medical Association.
241(2):194-207
[DOI] 10.2460/javma.241.2.194.
[PMID] 22765366.
2012
Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects.
Veterinary immunology and immunopathology.
146(2):185-9
[DOI] 10.1016/j.vetimm.2012.02.013.
[PMID] 22436376.
2012
Transepidermal water loss in healthy and atopic dogs, treated and untreated: a comparative preliminary study.
Veterinary dermatology.
23(1):41-4, e9
[DOI] 10.1111/j.1365-3164.2011.01003.x.
[PMID] 21790811.
2011
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
Veterinary dermatology.
22(3):239-48
[DOI] 10.1111/j.1365-3164.2011.00967.x.
[PMID] 21414049.
2011
Expression and distribution of canine antimicrobial peptides in the skin of healthy and atopic beagles.
Veterinary immunology and immunopathology.
144(3-4):382-8
[DOI] 10.1016/j.vetimm.2011.08.004.
[PMID] 21889803.
2010
A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Veterinary dermatology.
21(1):50-7
[DOI] 10.1111/j.1365-3164.2009.00773.x.
[PMID] 19843302.
2010
Canine atopic dermatitis: what’s new?
Compendium (Yardley, PA).
32(2):E1-4
[PMID] 20473848.
2010
Cutaneous periocular Habronema infection in a dromedary camel (Camelus dromedarius).
Veterinary dermatology.
21(5):527-30
[DOI] 10.1111/j.1365-3164.2009.00795.x.
[PMID] 20500499.
2010
Effects of age and allergen exposure on transepidermal water loss in a house dust mite-sensitized beagle model of atopic dermatitis.
Veterinary dermatology.
21(1):88-95
[DOI] 10.1111/j.1365-3164.2009.00839.x.
[PMID] 20187914.
2010
Environmental and oral challenge with storage mites in beagles experimentally sensitized to Dermatophagoides farinae.
Veterinary dermatology.
21(1):105-11
[DOI] 10.1111/j.1365-3164.2009.00859.x.
[PMID] 20187916.
2010
Investigation of the clinical efficacy of 0.2% topical stannous fluoride for the treatment of canine superficial pyoderma: a prospective, randomized, double-blinded, placebo-controlled trial.
Veterinary dermatology.
21(3):249-58
[DOI] 10.1111/j.1365-3164.2009.00785.x.
[PMID] 20230586.
2010
Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis.
Veterinary dermatology.
21(6):554-65
[DOI] 10.1111/j.1365-3164.2009.00786.x.
[PMID] 20609208.
2010
Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
Veterinary dermatology.
21(6):566-71
[DOI] 10.1111/j.1365-3164.2010.00890.x.
[PMID] 20492623.
2010
Transmission electron microscopy studies in an experimental model of canine atopic dermatitis.
Veterinary dermatology.
21(1):81-8
[DOI] 10.1111/j.1365-3164.2009.00802.x.
[PMID] 20042040.
2009
Canine models of atopic dermatitis: a useful tool with untapped potential.
The Journal of investigative dermatology.
129(10):2351-7
[DOI] 10.1038/jid.2009.98.
[PMID] 19516261.
2009
Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs.
American journal of veterinary research.
70(6):735-40
[DOI] 10.2460/ajvr.70.6.735.
[PMID] 19496662.
2009
Immunohistochemical evaluation of filaggrin polyclonal antibody in atopic and normal beagles.
Veterinary dermatology.
20(5-6):547-54
[DOI] 10.1111/j.1365-3164.2009.00844.x.
[PMID] 20178493.
2009
Performance characteristics of a monoclonal antibody cocktail-based ELISA for detection of allergen-specific IgE in dogs and comparison with a high affinity IgE receptor-based ELISA.
Veterinary dermatology.
20(3):157-64
[DOI] 10.1111/j.1365-3164.2009.00740.x.
[PMID] 19374726.
2009
Temporal dynamic changes of phenotypic expression of peripheral CD4 cells during environmental allergen challenge in an experimental model of canine atopic dermatitis: a pilot study.
The Journal of veterinary medical science.
71(9):1177-81
[PMID] 19801897.
2009
Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites.
Veterinary dermatology.
20(5-6):533-40
[DOI] 10.1111/j.1365-3164.2009.00809.x.
[PMID] 20178491.
2008
Assessment of cross-reactivity among five species of house dust and storage mites.
Veterinary dermatology.
19(2):67-76
[DOI] 10.1111/j.1365-3164.2008.00654.x.
[PMID] 18336423.
2007
Allergen challenge decreases mRNA expression of regulatory cytokines in whole blood of high-IgE beagles.
Veterinary dermatology.
18(6):422-6
[PMID] 17991159.
2007
Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy.
Veterinary dermatology.
18(4):246-51
[PMID] 17610490.
2007
Investigation on the clinical efficacy and tolerability of a 0.4% topical stannous fluoride preparation (MedEquine Gel) for the treatment of bacterial skin infections in horses: a prospective, randomized, double-blinded, placebo-controlled clinical trial.
Veterinary dermatology.
18(6):444-50
[PMID] 17991163.
2007
The clinical and histopathological effects of prednisone on acute radiation-induced dermatitis in dogs: a placebo-controlled, randomized, double-blind, prospective clinical trial.
Veterinary dermatology.
18(4):217-26
[PMID] 17610486.
2007
Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.
Veterinary dermatology.
18(2):78-86
[PMID] 17355421.
2006
Atopy: new targets and new therapies.
The Veterinary clinics of North America. Small animal practice.
36(1):161-74, vii
[PMID] 16364782.
2006
Cellular and cytokine kinetics after epicutaneous allergen challenge (atopy patch testing) with house dust mites in high-IgE beagles.
Veterinary dermatology.
17(2):111-20
[PMID] 16515653.
2006
Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
American journal of veterinary research.
67(9):1621-7
[PMID] 16948611.
2006
Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs.
Veterinary dermatology.
17(1):24-35
[PMID] 16412117.
2006
Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites.
Veterinary dermatology.
17(5):306-12
[PMID] 16961815.
2005
Atopy patch test reactions in high-IgE beagles to different sources and concentrations of house dust mites.
Veterinary dermatology.
16(5):308-14
[PMID] 16238810.
2005
Calcineurin inhibitors: a novel approach to canine atopic dermatitis.
Journal of the American Animal Hospital Association.
41(2):92-7
[PMID] 15767651.
2005
Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs–a pilot study.
Veterinary dermatology.
16(3):171-6
[PMID] 15960630.
2004
Evaluation of adrenal function in small-breed dogs receiving otic glucocorticoids.
Veterinary dermatology.
15(6):363-8
[PMID] 15585011.
2004
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
Veterinary dermatology.
15(5):294-303
[PMID] 15500481.
2004
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs.
Veterinary dermatology.
15(4):218-24
[PMID] 15305928.
2003
Animal models of atopic dermatitis.
Clinics in dermatology.
21(2):122-33
[PMID] 12706330.
2003
Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.
Veterinary dermatology.
14(2):83-9
[PMID] 12662265.
2002
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study.
Veterinary dermatology.
13(4):203-10
[PMID] 12174182.
2002
PCR-based detection of Pythium and Lagendium DNA in frozen and ethanol-fixed animal tissues.
Veterinary dermatology.
13(4):187-94
[PMID] 12229858.
2002
The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.
Veterinary dermatology.
13(3):131-9
[PMID] 12074702.
2001
Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis.
Veterinary dermatology.
12(4):189-95
[PMID] 11493402.
2001
Intradermal skin test reactivity to histamine and substance P is blunted in dogs with atopic dermatitis.
Veterinary dermatology.
12(3):149-54
[PMID] 11420930.
2001
Sulphido-leukotriene production from peripheral leukocytes and skin in clinically normal dogs and house dust mite positive atopic dogs.
Veterinary dermatology.
12(1):3-12
[PMID] 11301537.
2001
The ACVD task force on canine atopic dermatitis (VII): mediators of cutaneous inflammation.
Veterinary immunology and immunopathology.
81(3-4):205-13
[PMID] 11553381.
2001
The ACVD task force on canine atopic dermatitis (XIII): threshold phenomenon and summation of effects.
Veterinary immunology and immunopathology.
81(3-4):251-4
[PMID] 11553387.
2001
The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy.
Veterinary immunology and immunopathology.
81(3-4):331-45
[PMID] 11553396.
2001
Update on the role of leukotrienes in the pathogenesis of atopy: a comparative review.
Veterinary dermatology.
12(2):63-74
[PMID] 11360339.
2000
A Scoring Index for Clinical Signs of Flea Allergy Dermatitis in the cat.
Veterinary therapeutics : research in applied veterinary medicine.
1(4):213-9
[PMID] 19757567.
2000
Double-blind, placebo-controlled study to evaluate two miconazole conditioners for the treatment of Malassezia dermatitis in dogs.
Veterinary therapeutics : research in applied veterinary medicine.
1(3):141-9
[PMID] 19757576.
2000
Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration.
American journal of veterinary research.
61(6):631-7
[PMID] 10850837.
1999
Advances in flea control.
The Veterinary clinics of North America. Small animal practice.
29(6):1407-24
[PMID] 10563008.
1997
Double-blind pilot study on the effects of ketoconazole on intradermal skin test and leukotriene C4 concentration in the skin of atopic dogs.
Veterinary dermatology.
8(1):3-10
[DOI] 10.1111/j.1365-3164.1997.tb00257.x.
[PMID] 34645031.
1997
Use of pentoxifylline in the treatment of allergic contact reactions to plants of the Commelinceae family in dogs.
Veterinary dermatology.
8(2):121-126
[DOI] 10.1046/j.1365-3164.1997.d01-6.x.
[PMID] 34645064.
Grants
Jun 2025
ACTIVE
Characterization of Antibodies against Equine IL-31
Role: Principal Investigator
Funding: GRAYSON JOCKEY CLUB RES FOU
Feb 2025
ACTIVE
Pilot study to assess the clinical efficacy of immune Ig and anti-idiotypic Ig in dogs with allergic skin diseases
Role: Principal Investigator
Funding: NETWORK IMMUNOLOGY
Mar 2024
ACTIVE
Phase II – The JILL Study Argenta Merck – Protocol Number S21068-00: Evaluation of field safety and effectiveness of a novel oral JAK-1 inhibitor (AH386526 30 mg/g oral tablets for dogs) compared to active control for the control of atopic dermatitis in d
Role: Principal Investigator
Funding: ARGENTA
via MERCK ANIMAL HEALTH
May 2023
ACTIVE
D23CA-012: Investigation of Prevention Strategies and Treatment Options of Otitis in Dogs
Role: Principal Investigator
Funding: MORRIS ANIMAL FOU
Apr 2023
– Apr 2024
Protocol Number S21069-00: Evaluation of field safety and effectiveness of a novel oral JAK-1 inhibitor (AH386526 30 mg/g oral tablets for dogs) compared to placebo control for the control of pruritus associated with allergic dermatitis in dogs.
Role: Principal Investigator
Funding: ARGENTA
via MERCK ANIMAL HEALTH
Feb 2022
– Feb 2023
Development of a biologic against equine IL-31
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Jun 2021
– Feb 2024
The effect of probiotic vs. placebo on the clinical response and cytokine profile in felines with allergic dermatitis: a randomized, double blinded controlled study.
Role: Other
Funding: NESTLE PURINA PETCARE COMPANY
Aug 2020
– Sep 2021
Effect of supplement on skin lipid concentration in healthy dogs
Role: Principal Investigator
Funding: NUTRAMAX LABORATORIES VETERINARY SCIENCE
Jul 2020
– Jun 2021
Topical bacteriophage therapy for staphylococcal superficial pyoderma in horses: a proof of concept study
Role: Other
Funding: AMER COL OF VET DERMATOLOGY
Jun 2020
– Jun 2023
Topical bacteriophage therapy for staphylococcal superficial pyoderma in horses: a pilot study
Role: Principal Investigator
Funding: AUS AND NZL COLLEGE OF VET SCIENTISTS
May 2020
– Apr 2021
The Development of a Protocol for Evaluating Probiotic Treatment of Canine Atopic Dermatitis
Role: Principal Investigator
Funding: ARCHER DANIELS MIDLAND COMPANY
Nov 2019
– Oct 2020
Investigation of the role of IL-33 on atopic dermatitis
Role: Principal Investigator
Funding: SCOUT BIO
May 2019
– Apr 2020
Investigation of OKV-1001, an extended release mycophenolic acid, in a canine model of atopic dermatitis.
Role: Principal Investigator
Funding: OKAVA PHARMACEUTICALS
Feb 2019
– Aug 2021
Genetics analysis of an established colony of laboratory beagles with atopic dermatitis
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Sep 2018
– Feb 2020
Oclacitinib and its role on dendritic cell cytokine release in atopic and normal dogs, in vitro, a pilot study
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Aug 2018
– Aug 2020
Determination of effects of topical WOL071-308 in a colony of atopic Beagles
Role: Principal Investigator
Funding: DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTE
Feb 2017
– Mar 2018
Pilot study to evaluate the clinical efficacy of Donepezil to decrease signs of atopic dermatitis in an experimental model using high IgE producing Beagles
Role: Principal Investigator
Funding: NEURODERMA
Aug 2016
– Jun 2018
Pilot Study using microencapsulated Diindolylmethane (DIM) to modulate the inflammatory response in a canine model of atopic dermatitis
Role: Principal Investigator
Funding: BIORESPONSE LLC
Aug 2016
– Aug 2017
PILOT STUDY TO EVALUATE THE EFFECTS OF AN ORAL SUPPLEMENT ON SKIN BARRIER FUNCTION
Role: Principal Investigator
Funding: BIOIBERICA S A
Apr 2016
– Mar 2018
PILOT INVESTIGATIONS ON THE EFFECTS OF A JAK1/2 INHIBITOR ONSKIN BARRIER FUNCTION
Role: Principal Investigator
Funding: UF FOUNDATION
Mar 2016
– Mar 2017
Determination of Effects of WOL067-531, a Modulator of the Endocannabinoid System, in a Canine Animal Model of Atopic Dermatitis Beagles
Role: Principal Investigator
Funding: DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTE
Jan 2016
– Jan 2017
August Wolff Consulting Agreement
Role: Principal Investigator
Funding: DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTE
Sep 2015
– Jun 2016
A study to evaluate the clinical efficacy of SAR346923B
Role: Principal Investigator
Funding: MERIAL (USA)
Aug 2015
– Aug 2016
Pilot Study to Evaluate The Effects of a Topical Formulation Alone or in Combination with an Oral Supplement on Skin Barrier Function and Clinical Signs in Dogs With Atopic Dermatitis
Role: Principal Investigator
Funding: BIOIBERICA S A
Jun 2015
– Jun 2018
Clinical evaluation of DP955 to treat canine otitis
Role: Principal Investigator
Funding: DECHRA PHARMACEUTICALS
Dec 2014
– Apr 2016
In Vitro Efficacy of an H4R Antagonist to Affect Cytokines Involved in Atopic Dermatitis
Role: Principal Investigator
Funding: MERIAL (USA)
Feb 2014
– Feb 2016
House dust mites and canine atopic dermatitis: effects on toll like receptors, NF-+?B/STAT3, and the inflammasome complex
Role: Principal Investigator
Funding: AMER COL OF VET DERMATOLOGY
Education
Diplomate
1996
·
American College of Veterinary Dermatology
DVM, Veterinary Medicine (Summa cum Laude)
1991
·
Universita’ degli Studi Di Milano
Contact Details
Phones:
- Business:
- (352) 392-2235
Emails:
- Business:
- marsella@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100126
GAINESVILLE FL 32610 - Business Street:
-
2015 SW 16TH AVE
GAINESVILLE FL 32608